MUREX BIOTECH LIMITED
ActiveKey figures
† MUREX BIOTECH LIMITED filed these accounts on paper, so Companies House publishes them only as a scanned image. The figures for the years marked † were read automatically from the scan and kept only where the statements add up (for example net assets equal total equity), but a reading error is still possible — check the original accounts at Companies House.
MUREX BIOTECH LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024Sector comparison
SIC 32990Where the company stands among the 16,354 active companies whose first SIC code is 32990 (Other manufacturing n.e.c.).
- MATRIX MICROSCIENCE LIMITED£11.5bn
- LIFE TECHNOLOGIES LIMITED£3.7bn
- GKN LIMITED£1.9bn
- CCL INDUSTRIES (U.K.) LIMITED£550.4m
- THE VALSPAR (UK) HOLDING CORPORATION LIMITED£496.6m
- HEALTH AND HAPPINESS (H&H) UK LIMITED£448.7m
- GOODRICH CONTROL SYSTEMS£408.6m
- MBDA UK LIMITED£371.2m
- VOLUTION GROUP PLC£309.8m
- ALGECO UK LIMITED£250.5m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 16,354. The line on each bar marks the median.
Summary: MUREX BIOTECH LIMITED
What kind of company is it?
MUREX BIOTECH LIMITED is a private limited company registered with Companies House under company number 02670649. It was incorporated on 12 Dec 1991. Its status is active. The registered office is in Maidenhead (SL6). Its nature of business (SIC 2007) is other manufacturing n.e.c. (32990).
How is the company doing financially?
The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files full accounts. Profit for the year was £1,717,000. Net assets were £46,479,000, up 3.8% on the previous year. Total assets were £47,513,000 and total liabilities £1,034,000. Figures are available for 2 financial years (2023–2024).
How does it compare with similar companies?
Compared with 16,354 active companies whose first SIC code is 32990: By net assets it ranks higher than 99% of them (median £45,188). By total assets it ranks higher than 99% of them (median £157,459). It is older than 86% of them (median age 13.6 years).
Who runs and controls the company?
One person with significant control is registered. 1 of 2 registered charges are outstanding.
When are its next filings due?
The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 30 Nov 2026.
Filed accounts2023–2024
| 2023 † | 2024 † | |
|---|---|---|
| Profit for the year | 1,526,000 | 1,717,000 |
| Total assets | 45,197,000 | 47,513,000 |
| Total liabilities | 435,000 | 1,034,000 |
| Net assets / total equity | 44,762,000 | 46,479,000 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
History
4 events- Financial year 2024 endedAccounts: net assets £46.5m
- Financial year 2023 endedAccounts: net assets £44.8m
- Abbott Laboratories Ltd registered as a person with significant control
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.